1. 1ISG-010 Introduction of rituximab biosimilar: an opportunity to improve health system efficiency?. (24th March 2020) Authors: Panciroli, C; Cervi, L; Mazza, D; Mangoni, G; Dall'aglio, M; Ruggiero, F; Medaglia, ML Journal: European journal of hospital pharmacy Issue: Volume 27(2020)Supplement 1 Page Start: A4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 3PC-015 Short term stability of diluted solutions of the monoclonal antibody daratumumab. (24th March 2020) Authors: Mangoni, G; Selmin, F; Camuffo, L; Cancanelli, L; Piccoli, M; Rivano, M; Cervi, L; Cilurzo, F; Minghetti, P Journal: European journal of hospital pharmacy Issue: Volume 27(2020)Supplement 1 Page Start: A28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 4CPS-197 Monitoring of off-label use: analysis of prescriptions in the pharmacy's antiblastic drugs unit. (24th March 2020) Authors: Panciroli, C; Cervi, L; Mazza, D; Cavallo, L; Mangoni, G; Corru', F; Dall'aglio, M; Ruggiero, F; Medaglia, MLA Journal: European journal of hospital pharmacy Issue: Volume 27(2020)Supplement 1 Page Start: A141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗